Arrowhead Pharmaceuticals
ARWR
#2055
Rank
โ‚น889.55 B
Marketcap
โ‚น6,353
Share price
0.30%
Change (1 day)
269.24%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): -โ‚น104.69

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น114.55. In 2024 the company made an earnings per share (EPS) of -โ‚น458.20 a decrease over its 2023 EPS that were of -โ‚น175.30.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น104.69-77.15%
2024-โ‚น458.20161.39%
2023-โ‚น175.3017.36%
2022-โ‚น149.3719.85%
2021-โ‚น124.6361.9%
2020-โ‚น76.98-216.67%
2019โ‚น65.98-210.77%
2018-โ‚น59.5738.3%
2017-โ‚น43.07-64.93%
2016-โ‚น122.80-16.25%
2015-โ‚น146.6328%
2014-โ‚น114.55-3.85%
2013-โ‚น119.13-31.58%
2012-โ‚น174.12331.82%
2011-โ‚น40.32-51.11%
2010-โ‚น82.48-79.07%
2009-โ‚น394.06-37.68%
2008-โ‚น632.32-16.87%
2007-โ‚น760.6238.33%
2006-โ‚น549.85122.22%
2005-โ‚น247.4342.11%
2004-โ‚น174.12533.33%
2003-โ‚น27.49-99.08%
2002-โ‚น2,97525%
2001-โ‚น2,38033.33%
2000-โ‚น1,785-120%
1999โ‚น8,926-400%
1998-โ‚น2,975-81.48%
1997-โ‚น16,067

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น956.68-935.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚น739.54 545.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น219.02-291.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น8.25-107.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚น263.93 130.40%๐Ÿ‡บ๐Ÿ‡ธ USA